Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Earnings Preview For Kala Pharmaceuticals

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Kala Pharmaceuticals will report an earnings per share (EPS) of $-0.36.

Benzinga

Preview: Gracell Biotechnologies's Earnings

Gracell Biotechnologies (NASDAQ:GRCL) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Gracell Biotechnologies will report an earnings per share (EPS) of $-0.21.

Benzinga

Earnings Outlook For Compugen

Compugen (NASDAQ:CGEN) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Compugen will report an earnings per share (EPS) of $-0.13.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Preview For Wix.com

Wix.com (NASDAQ:WIX) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Wix.com will report an earnings per share (EPS) of $-0.64.

Benzinga

56 Stocks Moving In Friday's Mid-Day Session

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.

Benzinga

Analyst Ratings for Prometheus Biosciences

Analysts have provided the following ratings for Prometheus Biosciences (NASDAQ:RXDX) within the last quarter:

Benzinga

Impel NeuroPharma Earnings Preview

Impel NeuroPharma (NASDAQ:IMPL) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Impel NeuroPharma will report an earnings per share (EPS) of $-1.05.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Peering Into Plug Power's Recent Short Interest

Plug Power's (NASDAQ:PLUG) short percent of float has fallen 3.34% since its last report. The company recently reported that it has 63.29 million shares sold short, which is 12.45% of all regular shares that are available for trading.

Benzinga

Morgan Stanley Maintains Overweight Rating for CyberArk Software: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of CyberArk Software (NASDAQ:CYBR) and lower its price target from $191.00 to $172.00. Shares of CyberArk Software are trading up 9.01% over the last 24 hours, at $131.36 per share.

Benzinga

SVB Leerink Maintains Outperform Rating for Olink Holding: Here's What You Need To Know

SVB Leerink has decided to maintain its Outperform rating of Olink Holding (NASDAQ:OLK) and lower its price target from $25.00 to $20.00. Shares of Olink Holding are trading up 5.12% over the last 24 hours, at $11.50 per share.

Benzinga

Greenlane Expands Into Latin American Cannabis Market Via Agreement With Universal Distribution

Greenlane Holdings, Inc. (NASDAQ: GNLN) has entered into a distribution agreement with Universal Distribution LATAM LLC to distribute its proprietary portfolio of house brands in Latin America.

Benzinga

Why Should Investors Keep An Eye On Aurora Cannabis Stock Despite A Weak Quarter?

Aurora Cannabis Inc. (NASDAQ: ACB) reported financial and operational results late Thursday for the third quarter of fiscal 2022 ended March 31, 2022.

Benzinga

Amid Slowing Sales at Home, Innovent Biologics Stumbles Overseas

Key takeaways: Innovent Biologics terminated a plan to sell its bevacizumab biosimilar in North America with a local partner after trials for the drug fell behind schedule The company’s loss tripled last year on growing competition for its core product, whose sales fell 22% in this year’s first-quarter

Benzinga

Why Affirm Shares Are Rising

Affirm Holdings Inc (NASDAQ: AFRM) shares are trading higher by 22.24% at $22.05. The company Thursday reported better-than-expected third-quarter EPS and sales results.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

22nd Century Group Acquires Privately-Held Cannabis & Hemp Co., Here's What's Next

22nd Century Group, Inc. (NASDAQ: XXII) announced the acquisition of privately held GVB Biopharma. GVB - a contract development and manufacturing organization - provides hemp-derived active ingredients for the pharmaceutical and consumer goods industries worldwide.

Benzinga

Why Applied UV Shares Are Surging Today

Applied UV Inc (NASDAQ:AUVI) subsidiary MunnWorks, a custom manufacturer of luxury mirrors and furniture for the hospitality market, has received a model room order from the Renaissance Cleveland Hotel. Upon successful acceptance of the Model Room order, a follow-on $2 million order is expected. The furnishing will be done in a 100,000 square…

Benzinga

Greenlane Inks Distribution Deal To Expand In Latin America Market

Greenlane Holdings Inc (NASDAQ:GNLN) entered into a distribution agreement with Universal Distribution LATAM LLC to distribute its house brands in Latin America. Under the agreement terms, Greenlane has granted Universal Distribution the exclusive right to promote, market, distribute and sell the Greenlane Brands to retailers for resale in Chile, Uruguay, and Argentina. Greenlane…

Benzinga

Why Indie Semiconductor Shares Are Rising

Indie Semiconductor Inc (NASDAQ: INDI) shares are trading higher by 29.26% at $6.98 after the company reported better-than-expected first-quarter EPS and sales results.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With NFLX

A whale with a lot of money to spend has taken a noticeably bearish stance on Netflix. Looking at options history for Netflix (NASDAQ:NFLX) we detected 40 strange trades.

Benzinga

What Are Whales Doing With Trade Desk

A whale with a lot of money to spend has taken a noticeably bullish stance on Trade Desk. Looking at options history for Trade Desk (NASDAQ:TTD) we detected 17 strange trades.

Benzinga

LGVN: CEO Leaving but Progress Continues

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

Jefferies Downgrades Vodafone For First Time In 2 Years

Jefferies downgraded Vodafone Group Plc (NASDAQ:VOD) for the first time in two years, citing the telecom group's vulnerability in tackling rising inflation and headwinds in Germany, Reuters notes. Analyst Jerry Dellis noted that Vodafone is facing intense competition in several key markets amid rising costs. He downgraded the company to Hold from Buy. Also Read: Vodafone…

Benzinga

Starbucks And 2 Other Stocks Insiders Are Buying

Although the Dow Jones jumped by more than 400 points on Friday, there were a few notable insider trades.

Benzinga

Elon Musk’s from-out-of-nowhere announcement that he was putting his acquisition of Twitter (NYSE: TWTR) on hold stirred criticism, cynicism a

Benzinga

S&W Seed Earnings Preview

S&W Seed (NASDAQ:SANW) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that S&W Seed will report an earnings per share (EPS) of $-0.09.

1 … 552 553 554 555

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.